5-methoxy-3,6-dihydro-2H-1,4-oxazin-2-one (5a). A dry flask was charged with 2-methoxy-2-oxoethyl 2-azidoacetate (3.20 g, 18.5 mmol), fitted with a Dean-Stark apparatus and condenser, and flushed with nitrogen. The starting material was dissolved in toluene (100 mL) and PPh 3 (4.85 g, 18.5 mmol) was added. After visible evolution of N 2 ceased, the reaction was heated to 90 °C. After 16 h at 90 °C, the reaction was cooled to RT and concentrated in vacuo. The resulting black residue was purified by Kügelrohr distillation (1 mmHg, 150 °C) to afford the title compound 5a (0.650 g, 27% yield) as a clear colorless oil: IR (film) 1678, 1437, 1188, 1119, 719, 694 methyl 2-(2-chloroacetoxy)propanoate. Methyl lactate (4.59 mL, 48.1 mmol) was dissolved in CH 2 Cl 2 (100 mL). Pyridine (7.75 mL, 96.2 mmol) was introduced to the solution and the reaction vessel was cooled to 0 °C. Chloroacetyl chloride (4.17 mL, 52.9 mmol) was added dropwise to the solution over 1 h. After stirring for 2.5 h, the reaction was warmed to RT, diluted with 1.0M HCl (50 mL) and extracted with CH 2 Cl 2 (50 mL). The organic layer was washed with sat. aq. NaHCO 3 (50 mL), dried (Na 2 SO 4 ), filtered, and concentrated in vacuo. The resulting residue (8.26 g) was purified by flash column chromatography on silica gel (gradient elution: 0à40% EtOAc in hexane) to afford the title compound (7.32 g, 83% yield) as clear oil: TLC (40% EtOAc in hexane), R f = 0.6 (KMnO 4 ); IR (film) 1744, 1167, 1094, 1045, 980, 789 5-methoxy-6-methyl-3,6-dihydro-2H-1,4-oxazin-2-one (5b). Prepared in a manner analogous to the preparation of 5a. The concentrated residue was purified by flash column chromatography on silica gel (gradient elution: 20à100% EtOAc in hexane) to afford product 5b (180 mg, 37% yield) as a colorless oil: IR (film) 1748, 1695, 1456, 1206, 1080, 1043, 773 cm -1 ; 1 H NMR (400MHz, CDCl 3 ) 4.92 (q, J = 1.6 Hz, 1H), 4.26 (s, 2H), 3.76 (s, 3H), 1.57 (d, J = 3.9 Hz, 3H); 13 C NMR (100MHz, CDCl 3 ) 167.7, 162.5, 72.70, 53.6, 47.7, 18.4 Methyl 2-(2-chloroacetoxy)-2-phenylacetate. Methyl mandelate (5.00 g, 30 mmol) was dissolved in CH 2 Cl 2 (100 mL). Pyridine (4.84 mL, 0.060 mol) was introduced to the solution and the reaction vessel was cooled to 0 °C. Chloroacetyl chloride (2.60 mL, 30 mmol) was added dropwise to the solution over 1 h. After 2 h, the reaction was warmed to RT, diluted with 1M HCl (30 mL) and extracted with CH 2 Cl 2 (30 mL). The organic layer was then washed with NaHCO 3 (30 mL), dried (Na 2 SO 4 ), filtered, and concentrated in vacuo. The resulting residue (8.25 g) was purified by flash column chromatography on silica gel (gradient elution: 0à30% EtOAc in hexane) to afford the title compound (6.47 g, 89% yield) as a clear oil: TLC (40% EtOAc in hexane) R f = 0.6 (CAM); IR (film) 1748, 1217, 1155, 1038, 735 Methyl 2-(2-azidoacetoxy)-2-phenylacetate. Methyl 2-((chlorocarbonyl)oxy)-2-phenylacetate (5.27 g, 21.8 mmol) was dissolved in butanone (140 mL), and NaN 3 (3.79 g, 58 mmol) was added, and the reaction was heated to 80 °C. After 24 h, the reaction vessel was cooled to RT diluted with Et 2 O, filtered, and the filtrate was concentrated in vacuo. The resulting clear oil (5.10 g, 94% yield) was >95% pure as judged by 1 H NMR and used without further purification.
PPh 3 PhMe 110 °C 5c 5-methoxy-6-phenyl-3,6-dihydro-2H-1,4-oxazin-2-one (5c). Prepared using a procedure modified slightly from the preparation of 5a and 5b: following addition of PPh 3 , the reaction was heated to reflux (110 °C) for 24 h. The concentrated residue was purified by flash column chromatography on silica gel (gradient elution: 5à50% EtOAc in Hexanes with 50% isocratic toluene additive) to afford the title compound (264 mg, 57% yield) as slightly yellow oil: TLC (15% EtOAc, 35% hexanes, 50% toluene), R f = 0.33 (CAM); IR ( 134.3, 129.4, 129.1, 126.4, 76.7, 53.9, 47.7 General procedure for the domino reaction leading to tricyclic pyridine products 13-15: dihydrooxazinone 5a, 5b, or 5c (0.3-0.6 mmol) was dissolved in toluene (0.12-0.15M) and DBU (1.5 equiv) was added. The reaction vessel was heated in an oil bath to a gentle reflux (110 °C) and 2-alkynlbenzaldehyde 10, 11, or 12 (1.5 equiv) in 1.0 mL of toluene was introduced slowly to the reaction over 2 h (using a syringe pump). After stirring for 16-22 h at 110 °C, the reaction was cooled to RT, transferred to a separatory funnel, and partitioned between sat. aq. NH 4 Cl (10 mL) and EtOAc (10 mL). The organic layer was removed and the aqueous portion was extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine (10 mL), dried (Na 2 SO 4 ), filtered through Celite, and concentrated in vacuo. The resulting residue was purified by flash column chromatography on silica gel. 163.9, 162.9, 149.2, 140.8, 140.5, 127.0, 126.9, 125.4, 124.9, 121.9, 108.7, 53.6, 38.9, 33.2, 30.9, 22.6, 13.9 6, 163.3, 147.7, 140.7, 139.7, 138.6, 128.6, 128.4, 128.3, 126.4, 126.1, 125.8, 124.7, 121.8, 109.4, 53.8, 38.7 
2-methoxy-3-methyl-9H-indeno[2,1-b]pyridine (14a).
Pyridine 14a was prepared from 5b and 10 following the representative procedure described in the manuscript for the preparation of 13a. Use of the syringe pump was unnecessary; addition of 10 in toluene to the reaction mixture was performed by dropwise addition over 15 min. Purification by flash column chromatography on silica gel (gradient elution: 0à20% EtOAc in hexanes) to afford the title compound 14a (11 
4-butyl-2-methoxy-3-methyl-9H-indeno[2,1-b]pyridine (14b).
Pyridine 14b was prepared from 5b and 11 following the representative procedure described in the manuscript for the preparation of 13a. Use of the syringe pump was unnecessary; addition of 11 in toluene to the reaction mixture was performed by dropwise addition over 15 min. Purification by flash column chromatography on silica gel (gradient elution: 0à10% EtOAc in hexane) afforded the title compound 8, 159.3, 146.8, 141.1, 140.9, 126.8, 126.7, 125.1, 124.9, 121.6, 116.1, 53.7, 38.6, 30.7, 29.3, 23.2, 14.0, 11.0 
2-methoxy-3-methyl-4-phenyl-9H-indeno[2,1-b]pyridine (14c).
Pyridine 14c was prepared from 5b and 12 following the representative procedure described in the manuscript for the preparation of 13a. Use of the syringe pump was unnecessary; addition of 12 in toluene to the reaction mixture was performed by dropwise addition over 15 min. 162.0, 159.0, 146.0, 140.9, 140.4, 138.0, 128.9, 128.3, 127.9, 126.6, 126.4, 125.3, 124.6, 121.3, 116.7, 53.9, 38.4, 12.6 160.7, 140.6, 139.9, 137.5, 130.3, 129.4, 128.9, 127.4, 127.0, 126.1, 125.0, 122.8, 119.4, 53.9, 38.5 
4-butyl-2-methoxy-3-phenyl-9H-indeno[2,1-b]pyridine (15b).
Pyridine 15b was prepared from 5c and 11 following the representative procedure described in the manuscript for the preparation of 13a. Use of the syringe pump was unnecessary; addition of 11 in toluene to the reaction mixture was performed by dropwise addition over 15 min. Purification by flash column chromatography on silica gel (gradient elution: 0à10% EtOAc in hexane with an isocratic 50% toluene additive) afforded the title compound (25 mg, 50% yield) as a light yellow oil: TLC (10% EtOAc/hexanes) R f = 0.3 (KMnO 4 ); IR (film) 1564, 1454, 1341 cm -1 ; 1 H NMR (400MHz, CDCl 3 ): 7.70 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 7.5 Hz, 1H), 7.46 (t, J = 7.0 Hz, 2H), 7.40 (t, J = 7.4 Hz, 2H), 7.30 (m, J = 7.0 Hz, 3H), 3.95 (s, 2H), 3.93 (s, 3H) , 2.76 (q, J = 8.2 Hz, 2H), 1.54 (m, J = 6.6 Hz, 2H), 1.30 (m, J = 7.4 Hz, 2H), 0.80 (t, J = 7.4 Hz, 3H); 13 C NMR (100 MHz, CDCl 3 ): 161.5, 147.1, 141.0, 136.2, 130.3, 128.1, 127.1, 127.0, 126.8, 125.4, 124.9, 121.8, 72.1, 54.0, 38.9, 31.3, 29.8, 22.9, 13.7 161.4, 161.0, 140.8, 140.2, 137.2, 135.4, 130.9, 129.1, 128.2, 127.5, 127.4, 126.8, 126.6, 126.5, 125.6, 124.7, 122.1, 121.7, 77.2, 54.1, 38.7 
